Claris Bio
Business Services · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Jersey City, New Jersey, United StatesWebsite
www.clarisbio.comRevenue
$5.3 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Claris Bio
Established in 2020, Claris Bio is developing a recombinant human variant hepatocyte growth factor, dHGF, to accelerate and improve the quality of corneal healing in patients with corneal eye disease.Explore more
Claris Bio Org Chart
RC
Senior Project Manager, Clinical
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Claris Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Claris Bio had a recent Job posting/layoffs
Claris Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Claris Bio launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Claris Bio has new funding data
Congratulate Masked Content for being promoted to Masked Content at Claris Bio
Check if Claris Bio has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Claris Bio recently announced quarterly report
Check out if Claris Bio is spiking on competitors!
Recommended Actions
Find VP level buyers at Claris Bio
Find 3 more new buyers
Compare Similar Companies to Claris Bio
Compare insights from companies similar to Claris Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Claris Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Claris Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Claris Bio.
Claris Bio financials insights
Gather financial insights about Claris Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series A
$57M
2026
Series B
$118M
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire, Board of Directors
New Hire
Executive Move
Executive Moves, New Hire, Board of Directors
Executive Move
Executive Moves, Board of Directors
Funding
Funding
Funding
Claris Bio News & Media
Claris Bio Unveils Development Strategy, Planned Pivotal Study Supported by $118 Million Series B Financing from Top-Tier Investors, and Multiple Leadership Appointments
Positive proof-of-concept clinical data show substantial improvements in visual acuity in limbal stem cell deficiency (LSCD) patients treated with CSB-001
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Claris Bio
Sign Up For FreeTo access detailed company insights
Established in 2020, Claris Bio is developing a recombinant human variant hepatocyte growth factor, dHGF, to accelerate and improve the quality of corneal healing in patients with corneal eye disease.... Read More
